Crossmark

Hyaluronan derived nanoparticle for simvastatin delivery: evaluation of simvastatin induced myotoxicity in tissue engineered skeletal muscle

Crossref DOI link: https://doi.org/10.1039/c9bm00986h

Published Online: 2020

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Jones, Julia M.

Player, Darren J. https://orcid.org/0000-0003-2867-5416
Samanta, Sumanta https://orcid.org/0000-0002-1967-2232
Rangasami, Vignesh K. https://orcid.org/0000-0001-8151-5310
Hilborn, Jöns

Lewis, Mark P. https://orcid.org/0000-0002-8430-4479
Oommen, Oommen P. https://orcid.org/0000-0003-2768-0133
Mudera, Vivek
Funding

Funding for this research was provided by:

FP7 Health (262948)

H2020 Marie Skłodowska-Curie Actions (713645)

University College London
License Information

Version of Record valid from 2019-11-01
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Darren J. Player (ORCID)

: Sumanta Samanta (ORCID)

: Sumanta Samanta (ResearcherID)

: Vignesh K. Rangasami (ORCID)

: Mark P. Lewis (ORCID)

: Oommen P. Oommen (ORCID)

: Oommen P. Oommen (ResearcherID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 25 June 2019; Accepted 31 October 2019; Accepted Manuscript published 1 November 2019; Advance Article published 8 November 2019; Version of Record published 17 December 2019